Anaeropharma Science

A privately held biopharmaceutical company based in Tokyo, Japan, Anaeropharma Science was established in 2004 to pioneer the development of novel therapeutics to target such a hypoxic environment in solid cancers based on its proprietary platform technology, recombinant bifidobacterium therapeutics. » Read full article

Anaeropharma’s Technology was introduced on Nikkei Business Daily.  November 30, 2009

Anaeropharma CEO is interviewed by Venture Valuation, a Swiss information providing firm in the emerging industries.
Read more to visit Venture Valuation’s website.

• Anaeropharma Science interview article (PDF)

http://www.jst.go.jp/pr/jst-news/2008/2008-07/page08.html